nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—Oxcarbazepine—epilepsy syndrome	0.316	1	CrCtD
Mianserin—HTR7—epilepsy syndrome	0.0482	0.288	CbGaD
Mianserin—ADRA2A—epilepsy syndrome	0.0413	0.247	CbGaD
Mianserin—SLC6A4—epilepsy syndrome	0.0315	0.188	CbGaD
Mianserin—HTR2A—epilepsy syndrome	0.0242	0.145	CbGaD
Mianserin—Epinastine—Carbamazepine—epilepsy syndrome	0.0238	0.108	CrCrCtD
Mianserin—CYP2D6—epilepsy syndrome	0.0222	0.132	CbGaD
Mianserin—Epinastine—Oxcarbazepine—epilepsy syndrome	0.0219	0.0996	CrCrCtD
Mianserin—Phenindamine—Oxcarbazepine—epilepsy syndrome	0.0171	0.0777	CrCrCtD
Mianserin—Cyproheptadine—Carbamazepine—epilepsy syndrome	0.0161	0.0729	CrCrCtD
Mianserin—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.0126	0.0572	CrCrCtD
Mianserin—Oxcarbazepine—Carbamazepine—epilepsy syndrome	0.0116	0.0527	CrCrCtD
Mianserin—Desipramine—Carbamazepine—epilepsy syndrome	0.0107	0.0485	CrCrCtD
Mianserin—CYP2B6—Fosphenytoin—epilepsy syndrome	0.0106	0.077	CbGbCtD
Mianserin—Oxcarbazepine—Clobazam—epilepsy syndrome	0.0103	0.0466	CrCrCtD
Mianserin—Desipramine—Oxcarbazepine—epilepsy syndrome	0.00983	0.0446	CrCrCtD
Mianserin—Chlorcyclizine—Clobazam—epilepsy syndrome	0.00969	0.044	CrCrCtD
Mianserin—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00958	0.0435	CrCrCtD
Mianserin—Oxcarbazepine—Diazepam—epilepsy syndrome	0.00953	0.0433	CrCrCtD
Mianserin—Trimipramine—Carbamazepine—epilepsy syndrome	0.00943	0.0428	CrCrCtD
Mianserin—CYP2B6—Clobazam—epilepsy syndrome	0.0092	0.0668	CbGbCtD
Mianserin—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.00869	0.0395	CrCrCtD
Mianserin—Imipramine—Carbamazepine—epilepsy syndrome	0.00865	0.0393	CrCrCtD
Mianserin—Methdilazine—Carbamazepine—epilepsy syndrome	0.00848	0.0385	CrCrCtD
Mianserin—Imipramine—Oxcarbazepine—epilepsy syndrome	0.00797	0.0362	CrCrCtD
Mianserin—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.00781	0.0355	CrCrCtD
Mianserin—CYP2B6—Carbamazepine—epilepsy syndrome	0.00763	0.0554	CbGbCtD
Mianserin—CYP2B6—Primidone—epilepsy syndrome	0.00712	0.0517	CbGbCtD
Mianserin—CYP2B6—Phenytoin—epilepsy syndrome	0.00684	0.0496	CbGbCtD
Mianserin—Prochlorperazine—Clobazam—epilepsy syndrome	0.00647	0.0294	CrCrCtD
Mianserin—CYP2B6—Propofol—epilepsy syndrome	0.00638	0.0463	CbGbCtD
Mianserin—CYP2B6—Phenobarbital—epilepsy syndrome	0.0061	0.0442	CbGbCtD
Mianserin—CYP2B6—Midazolam—epilepsy syndrome	0.00601	0.0436	CbGbCtD
Mianserin—CYP2B6—Diazepam—epilepsy syndrome	0.00578	0.0419	CbGbCtD
Mianserin—CYP2B6—Valproic Acid—epilepsy syndrome	0.00456	0.0331	CbGbCtD
Mianserin—CYP1A2—Carbamazepine—epilepsy syndrome	0.00447	0.0325	CbGbCtD
Mianserin—CYP1A2—Primidone—epilepsy syndrome	0.00417	0.0303	CbGbCtD
Mianserin—CYP1A2—Propofol—epilepsy syndrome	0.00374	0.0271	CbGbCtD
Mianserin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00373	0.0271	CbGbCtD
Mianserin—CYP1A2—Phenobarbital—epilepsy syndrome	0.00357	0.0259	CbGbCtD
Mianserin—CYP3A4—Trimethadione—epilepsy syndrome	0.00347	0.0252	CbGbCtD
Mianserin—CYP3A4—Felbamate—epilepsy syndrome	0.00347	0.0252	CbGbCtD
Mianserin—CYP1A2—Diazepam—epilepsy syndrome	0.00339	0.0246	CbGbCtD
Mianserin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00326	0.0237	CbGbCtD
Mianserin—CYP2D6—Propofol—epilepsy syndrome	0.00308	0.0224	CbGbCtD
Mianserin—CYP3A4—Clonazepam—epilepsy syndrome	0.00295	0.0214	CbGbCtD
Mianserin—CYP3A4—Clobazam—epilepsy syndrome	0.00283	0.0205	CbGbCtD
Mianserin—CYP1A2—Valproic Acid—epilepsy syndrome	0.00267	0.0194	CbGbCtD
Mianserin—CYP3A4—Rufinamide—epilepsy syndrome	0.0024	0.0174	CbGbCtD
Mianserin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00234	0.017	CbGbCtD
Mianserin—HTR1D—meninx—epilepsy syndrome	0.00232	0.0713	CbGeAlD
Mianserin—CYP3A4—Primidone—epilepsy syndrome	0.00219	0.0159	CbGbCtD
Mianserin—CYP3A4—Phenytoin—epilepsy syndrome	0.0021	0.0152	CbGbCtD
Mianserin—CYP3A4—Propofol—epilepsy syndrome	0.00196	0.0142	CbGbCtD
Mianserin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00187	0.0136	CbGbCtD
Mianserin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00187	0.0136	CbGbCtD
Mianserin—CYP3A4—Midazolam—epilepsy syndrome	0.00185	0.0134	CbGbCtD
Mianserin—CYP3A4—Diazepam—epilepsy syndrome	0.00178	0.0129	CbGbCtD
Mianserin—CYP3A4—Zonisamide—epilepsy syndrome	0.00173	0.0126	CbGbCtD
Mianserin—CYP3A4—Valproic Acid—epilepsy syndrome	0.0014	0.0102	CbGbCtD
Mianserin—CYP3A4—Topiramate—epilepsy syndrome	0.00126	0.00916	CbGbCtD
Mianserin—HTR2A—phrenic nerve—epilepsy syndrome	0.00125	0.0383	CbGeAlD
Mianserin—DRD3—telencephalic ventricle—epilepsy syndrome	0.000949	0.0291	CbGeAlD
Mianserin—SLC6A2—locus ceruleus—epilepsy syndrome	0.000929	0.0285	CbGeAlD
Mianserin—HTR7—locus ceruleus—epilepsy syndrome	0.000895	0.0274	CbGeAlD
Mianserin—HTR1F—ganglion—epilepsy syndrome	0.000836	0.0256	CbGeAlD
Mianserin—HTR7—vagus nerve—epilepsy syndrome	0.000685	0.021	CbGeAlD
Mianserin—HTR6—ganglion—epilepsy syndrome	0.000569	0.0174	CbGeAlD
Mianserin—HTR2A—locus ceruleus—epilepsy syndrome	0.000558	0.0171	CbGeAlD
Mianserin—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000546	0.0167	CbGeAlD
Mianserin—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000533	0.0163	CbGeAlD
Mianserin—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000528	0.0162	CbGeAlD
Mianserin—HTR7—pons—epilepsy syndrome	0.000516	0.0158	CbGeAlD
Mianserin—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000494	0.0151	CbGeAlD
Mianserin—HTR7—autonomic nervous system—epilepsy syndrome	0.000476	0.0146	CbGeAlD
Mianserin—HTR2A—cerebellar cortex—epilepsy syndrome	0.000455	0.0139	CbGeAlD
Mianserin—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000444	0.0136	CbGeAlD
Mianserin—HTR2A—vagus nerve—epilepsy syndrome	0.000427	0.0131	CbGeAlD
Mianserin—HTR7—telencephalic ventricle—epilepsy syndrome	0.000425	0.013	CbGeAlD
Mianserin—DRD2—telencephalic ventricle—epilepsy syndrome	0.000401	0.0123	CbGeAlD
Mianserin—HTR1F—forebrain—epilepsy syndrome	0.000351	0.0108	CbGeAlD
Mianserin—SLC6A3—ganglion—epilepsy syndrome	0.00034	0.0104	CbGeAlD
Mianserin—HTR1D—ganglion—epilepsy syndrome	0.000332	0.0102	CbGeAlD
Mianserin—HTR2C—ganglion—epilepsy syndrome	0.000329	0.0101	CbGeAlD
Mianserin—HTR1F—telencephalon—epilepsy syndrome	0.000323	0.00989	CbGeAlD
Mianserin—HTR2A—pons—epilepsy syndrome	0.000322	0.00986	CbGeAlD
Mianserin—SLC6A4—ganglion—epilepsy syndrome	0.000311	0.00955	CbGeAlD
Mianserin—HTR2A—autonomic nervous system—epilepsy syndrome	0.000297	0.00909	CbGeAlD
Mianserin—HTR1A—ganglion—epilepsy syndrome	0.000277	0.00848	CbGeAlD
Mianserin—SLC6A2—ganglion—epilepsy syndrome	0.000274	0.0084	CbGeAlD
Mianserin—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000265	0.00811	CbGeAlD
Mianserin—HTR7—ganglion—epilepsy syndrome	0.000264	0.0081	CbGeAlD
Mianserin—SLC6A3—hindbrain—epilepsy syndrome	0.000258	0.0079	CbGeAlD
Mianserin—DRD2—ganglion—epilepsy syndrome	0.00025	0.00766	CbGeAlD
Mianserin—HTR6—forebrain—epilepsy syndrome	0.000239	0.00731	CbGeAlD
Mianserin—SLC6A4—hindbrain—epilepsy syndrome	0.000236	0.00724	CbGeAlD
Mianserin—OPRK1—forebrain—epilepsy syndrome	0.000221	0.00677	CbGeAlD
Mianserin—HTR6—telencephalon—epilepsy syndrome	0.000219	0.00672	CbGeAlD
Mianserin—HTR1A—hindbrain—epilepsy syndrome	0.00021	0.00643	CbGeAlD
Mianserin—HTR1F—head—epilepsy syndrome	0.000201	0.00616	CbGeAlD
Mianserin—HTR7—hindbrain—epilepsy syndrome	0.0002	0.00614	CbGeAlD
Mianserin—HTR1F—nervous system—epilepsy syndrome	0.00019	0.00584	CbGeAlD
Mianserin—DRD2—hindbrain—epilepsy syndrome	0.000189	0.00581	CbGeAlD
Mianserin—HTR1F—central nervous system—epilepsy syndrome	0.000183	0.00562	CbGeAlD
Mianserin—HTR2A—ganglion—epilepsy syndrome	0.000165	0.00505	CbGeAlD
Mianserin—SLC6A3—brainstem—epilepsy syndrome	0.000148	0.00453	CbGeAlD
Mianserin—HTR1F—brain—epilepsy syndrome	0.000146	0.00446	CbGeAlD
Mianserin—HTR1D—brainstem—epilepsy syndrome	0.000144	0.00442	CbGeAlD
Mianserin—HTR2C—brainstem—epilepsy syndrome	0.000143	0.00438	CbGeAlD
Mianserin—SLC6A3—forebrain—epilepsy syndrome	0.000143	0.00437	CbGeAlD
Mianserin—DRD3—head—epilepsy syndrome	0.000142	0.00435	CbGeAlD
Mianserin—HTR1D—forebrain—epilepsy syndrome	0.000139	0.00427	CbGeAlD
Mianserin—HTR2C—forebrain—epilepsy syndrome	0.000138	0.00422	CbGeAlD
Mianserin—HTR6—head—epilepsy syndrome	0.000137	0.00419	CbGeAlD
Mianserin—SLC6A4—brainstem—epilepsy syndrome	0.000135	0.00415	CbGeAlD
Mianserin—DRD3—nervous system—epilepsy syndrome	0.000135	0.00412	CbGeAlD
Mianserin—SLC6A3—telencephalon—epilepsy syndrome	0.000131	0.00402	CbGeAlD
Mianserin—SLC6A4—forebrain—epilepsy syndrome	0.000131	0.004	CbGeAlD
Mianserin—DRD3—central nervous system—epilepsy syndrome	0.00013	0.00397	CbGeAlD
Mianserin—HTR6—nervous system—epilepsy syndrome	0.000129	0.00397	CbGeAlD
Mianserin—HTR2B—forebrain—epilepsy syndrome	0.000129	0.00397	CbGeAlD
Mianserin—HTR1D—telencephalon—epilepsy syndrome	0.000128	0.00392	CbGeAlD
Mianserin—HTR2C—telencephalon—epilepsy syndrome	0.000127	0.00388	CbGeAlD
Mianserin—OPRK1—head—epilepsy syndrome	0.000126	0.00388	CbGeAlD
Mianserin—HTR2A—hindbrain—epilepsy syndrome	0.000125	0.00383	CbGeAlD
Mianserin—HRH2—head—epilepsy syndrome	0.000125	0.00383	CbGeAlD
Mianserin—HTR6—central nervous system—epilepsy syndrome	0.000125	0.00382	CbGeAlD
Mianserin—HTR1A—brainstem—epilepsy syndrome	0.00012	0.00368	CbGeAlD
Mianserin—SLC6A4—telencephalon—epilepsy syndrome	0.00012	0.00368	CbGeAlD
Mianserin—OPRK1—nervous system—epilepsy syndrome	0.00012	0.00367	CbGeAlD
Mianserin—SLC6A2—brainstem—epilepsy syndrome	0.000119	0.00365	CbGeAlD
Mianserin—HTR2B—telencephalon—epilepsy syndrome	0.000119	0.00365	CbGeAlD
Mianserin—HRH2—nervous system—epilepsy syndrome	0.000118	0.00363	CbGeAlD
Mianserin—HTR1A—forebrain—epilepsy syndrome	0.000116	0.00356	CbGeAlD
Mianserin—OPRK1—central nervous system—epilepsy syndrome	0.000115	0.00354	CbGeAlD
Mianserin—SLC6A2—forebrain—epilepsy syndrome	0.000115	0.00353	CbGeAlD
Mianserin—HTR7—brainstem—epilepsy syndrome	0.000115	0.00352	CbGeAlD
Mianserin—HRH2—central nervous system—epilepsy syndrome	0.000114	0.00349	CbGeAlD
Mianserin—CYP2D6—hindbrain—epilepsy syndrome	0.000114	0.00349	CbGeAlD
Mianserin—OPRK1—cerebellum—epilepsy syndrome	0.000113	0.00346	CbGeAlD
Mianserin—HTR7—forebrain—epilepsy syndrome	0.000111	0.0034	CbGeAlD
Mianserin—DRD2—brainstem—epilepsy syndrome	0.000109	0.00333	CbGeAlD
Mianserin—HTR1A—telencephalon—epilepsy syndrome	0.000107	0.00327	CbGeAlD
Mianserin—SLC6A2—telencephalon—epilepsy syndrome	0.000106	0.00324	CbGeAlD
Mianserin—DRD2—forebrain—epilepsy syndrome	0.000105	0.00321	CbGeAlD
Mianserin—DRD3—brain—epilepsy syndrome	0.000103	0.00315	CbGeAlD
Mianserin—HTR7—telencephalon—epilepsy syndrome	0.000102	0.00312	CbGeAlD
Mianserin—HTR2C—medulla oblongata—epilepsy syndrome	9.96e-05	0.00305	CbGeAlD
Mianserin—HTR6—brain—epilepsy syndrome	9.9e-05	0.00303	CbGeAlD
Mianserin—DRD2—telencephalon—epilepsy syndrome	9.64e-05	0.00295	CbGeAlD
Mianserin—SLC6A3—midbrain—epilepsy syndrome	9.42e-05	0.00289	CbGeAlD
Mianserin—ADRA2C—telencephalon—epilepsy syndrome	9.37e-05	0.00287	CbGeAlD
Mianserin—HTR1D—midbrain—epilepsy syndrome	9.19e-05	0.00282	CbGeAlD
Mianserin—SLC6A3—spinal cord—epilepsy syndrome	9.19e-05	0.00282	CbGeAlD
Mianserin—OPRK1—brain—epilepsy syndrome	9.16e-05	0.00281	CbGeAlD
Mianserin—HTR2C—midbrain—epilepsy syndrome	9.1e-05	0.00279	CbGeAlD
Mianserin—HRH2—brain—epilepsy syndrome	9.05e-05	0.00277	CbGeAlD
Mianserin—HTR2C—spinal cord—epilepsy syndrome	8.88e-05	0.00272	CbGeAlD
Mianserin—Mirtazapine—HRH3—epilepsy syndrome	8.74e-05	0.0439	CrCbGaD
Mianserin—Imipramine—KCND2—epilepsy syndrome	8.73e-05	0.0439	CrCbGaD
Mianserin—Amitriptyline—KCND2—epilepsy syndrome	8.67e-05	0.0436	CrCbGaD
Mianserin—SLC6A4—midbrain—epilepsy syndrome	8.63e-05	0.00264	CbGeAlD
Mianserin—SLC6A4—spinal cord—epilepsy syndrome	8.42e-05	0.00258	CbGeAlD
Mianserin—SLC6A2—medulla oblongata—epilepsy syndrome	8.31e-05	0.00255	CbGeAlD
Mianserin—HRH1—forebrain—epilepsy syndrome	8.28e-05	0.00254	CbGeAlD
Mianserin—SLC6A3—head—epilepsy syndrome	8.16e-05	0.0025	CbGeAlD
Mianserin—ADRA2A—forebrain—epilepsy syndrome	8.13e-05	0.00249	CbGeAlD
Mianserin—Amitriptyline—KCNQ2—epilepsy syndrome	8.06e-05	0.0405	CrCbGaD
Mianserin—Amitriptyline—KCNQ3—epilepsy syndrome	8.06e-05	0.0405	CrCbGaD
Mianserin—HTR7—medulla oblongata—epilepsy syndrome	8.01e-05	0.00245	CbGeAlD
Mianserin—HTR1D—head—epilepsy syndrome	7.97e-05	0.00244	CbGeAlD
Mianserin—HTR2C—head—epilepsy syndrome	7.89e-05	0.00242	CbGeAlD
Mianserin—SLC6A3—nervous system—epilepsy syndrome	7.74e-05	0.00237	CbGeAlD
Mianserin—HTR1A—midbrain—epilepsy syndrome	7.66e-05	0.00235	CbGeAlD
Mianserin—HRH1—telencephalon—epilepsy syndrome	7.61e-05	0.00233	CbGeAlD
Mianserin—HTR1D—nervous system—epilepsy syndrome	7.56e-05	0.00232	CbGeAlD
Mianserin—HTR2C—nervous system—epilepsy syndrome	7.48e-05	0.00229	CbGeAlD
Mianserin—SLC6A4—head—epilepsy syndrome	7.48e-05	0.00229	CbGeAlD
Mianserin—ADRA2A—telencephalon—epilepsy syndrome	7.48e-05	0.00229	CbGeAlD
Mianserin—HTR1A—spinal cord—epilepsy syndrome	7.47e-05	0.00229	CbGeAlD
Mianserin—SLC6A3—central nervous system—epilepsy syndrome	7.45e-05	0.00228	CbGeAlD
Mianserin—HTR2B—head—epilepsy syndrome	7.41e-05	0.00227	CbGeAlD
Mianserin—ADRA2C—medulla oblongata—epilepsy syndrome	7.36e-05	0.00226	CbGeAlD
Mianserin—HTR7—midbrain—epilepsy syndrome	7.32e-05	0.00224	CbGeAlD
Mianserin—SLC6A3—cerebellum—epilepsy syndrome	7.28e-05	0.00223	CbGeAlD
Mianserin—HTR1D—central nervous system—epilepsy syndrome	7.27e-05	0.00223	CbGeAlD
Mianserin—HTR2C—central nervous system—epilepsy syndrome	7.2e-05	0.00221	CbGeAlD
Mianserin—HTR2A—brainstem—epilepsy syndrome	7.16e-05	0.0022	CbGeAlD
Mianserin—HTR7—spinal cord—epilepsy syndrome	7.14e-05	0.00219	CbGeAlD
Mianserin—SLC6A4—nervous system—epilepsy syndrome	7.09e-05	0.00217	CbGeAlD
Mianserin—HTR2B—nervous system—epilepsy syndrome	7.03e-05	0.00215	CbGeAlD
Mianserin—DRD2—midbrain—epilepsy syndrome	6.92e-05	0.00212	CbGeAlD
Mianserin—HTR2A—forebrain—epilepsy syndrome	6.91e-05	0.00212	CbGeAlD
Mianserin—Amitriptyline—NTRK2—epilepsy syndrome	6.85e-05	0.0345	CrCbGaD
Mianserin—SLC6A4—central nervous system—epilepsy syndrome	6.83e-05	0.00209	CbGeAlD
Mianserin—HTR2B—central nervous system—epilepsy syndrome	6.77e-05	0.00207	CbGeAlD
Mianserin—ADRA2C—midbrain—epilepsy syndrome	6.73e-05	0.00206	CbGeAlD
Mianserin—Metixene—CHRM3—epilepsy syndrome	6.7e-05	0.0337	CrCbGaD
Mianserin—HTR1A—head—epilepsy syndrome	6.64e-05	0.00204	CbGeAlD
Mianserin—SLC6A2—head—epilepsy syndrome	6.59e-05	0.00202	CbGeAlD
Mianserin—ADRA2C—spinal cord—epilepsy syndrome	6.57e-05	0.00201	CbGeAlD
Mianserin—CYP2D6—brainstem—epilepsy syndrome	6.53e-05	0.002	CbGeAlD
Mianserin—HTR2A—telencephalon—epilepsy syndrome	6.36e-05	0.00195	CbGeAlD
Mianserin—HTR7—head—epilepsy syndrome	6.35e-05	0.00195	CbGeAlD
Mianserin—CYP2D6—forebrain—epilepsy syndrome	6.3e-05	0.00193	CbGeAlD
Mianserin—HTR1A—nervous system—epilepsy syndrome	6.3e-05	0.00193	CbGeAlD
Mianserin—Metixene—CHRM1—epilepsy syndrome	6.24e-05	0.0314	CrCbGaD
Mianserin—SLC6A2—nervous system—epilepsy syndrome	6.24e-05	0.00191	CbGeAlD
Mianserin—HTR1A—central nervous system—epilepsy syndrome	6.06e-05	0.00186	CbGeAlD
Mianserin—HTR7—nervous system—epilepsy syndrome	6.02e-05	0.00184	CbGeAlD
Mianserin—SLC6A2—central nervous system—epilepsy syndrome	6.01e-05	0.00184	CbGeAlD
Mianserin—DRD2—head—epilepsy syndrome	6e-05	0.00184	CbGeAlD
Mianserin—HTR1A—cerebellum—epilepsy syndrome	5.93e-05	0.00182	CbGeAlD
Mianserin—SLC6A3—brain—epilepsy syndrome	5.92e-05	0.00181	CbGeAlD
Mianserin—ADRA2A—medulla oblongata—epilepsy syndrome	5.87e-05	0.0018	CbGeAlD
Mianserin—ADRA2C—head—epilepsy syndrome	5.83e-05	0.00179	CbGeAlD
Mianserin—HTR7—central nervous system—epilepsy syndrome	5.79e-05	0.00178	CbGeAlD
Mianserin—CYP2D6—telencephalon—epilepsy syndrome	5.79e-05	0.00177	CbGeAlD
Mianserin—HTR1D—brain—epilepsy syndrome	5.78e-05	0.00177	CbGeAlD
Mianserin—HTR2C—brain—epilepsy syndrome	5.72e-05	0.00175	CbGeAlD
Mianserin—DRD2—nervous system—epilepsy syndrome	5.69e-05	0.00174	CbGeAlD
Mianserin—HTR7—cerebellum—epilepsy syndrome	5.66e-05	0.00174	CbGeAlD
Mianserin—ADRA2C—nervous system—epilepsy syndrome	5.53e-05	0.0017	CbGeAlD
Mianserin—DRD2—central nervous system—epilepsy syndrome	5.48e-05	0.00168	CbGeAlD
Mianserin—SLC6A4—brain—epilepsy syndrome	5.42e-05	0.00166	CbGeAlD
Mianserin—HTR2B—brain—epilepsy syndrome	5.37e-05	0.00165	CbGeAlD
Mianserin—ADRA2A—midbrain—epilepsy syndrome	5.37e-05	0.00165	CbGeAlD
Mianserin—DRD2—cerebellum—epilepsy syndrome	5.35e-05	0.00164	CbGeAlD
Mianserin—ADRA2C—central nervous system—epilepsy syndrome	5.33e-05	0.00163	CbGeAlD
Mianserin—ADRA2A—spinal cord—epilepsy syndrome	5.24e-05	0.00161	CbGeAlD
Mianserin—ADRA2C—cerebellum—epilepsy syndrome	5.21e-05	0.0016	CbGeAlD
Mianserin—Metixene—CHRM2—epilepsy syndrome	5.1e-05	0.0256	CrCbGaD
Mianserin—Cyproheptadine—CHRM3—epilepsy syndrome	5.07e-05	0.0255	CrCbGaD
Mianserin—Epinastine—HTR7—epilepsy syndrome	5.04e-05	0.0253	CrCbGaD
Mianserin—HTR2A—medulla oblongata—epilepsy syndrome	5e-05	0.00153	CbGeAlD
Mianserin—CYP2B6—head—epilepsy syndrome	4.85e-05	0.00149	CbGeAlD
Mianserin—HTR1A—brain—epilepsy syndrome	4.81e-05	0.00148	CbGeAlD
Mianserin—SLC6A2—brain—epilepsy syndrome	4.77e-05	0.00146	CbGeAlD
Mianserin—Mequitazine—CHRM2—epilepsy syndrome	4.76e-05	0.0239	CrCbGaD
Mianserin—HRH1—head—epilepsy syndrome	4.74e-05	0.00145	CbGeAlD
Mianserin—Cyproheptadine—CHRM1—epilepsy syndrome	4.73e-05	0.0238	CrCbGaD
Mianserin—ADRA2A—head—epilepsy syndrome	4.66e-05	0.00143	CbGeAlD
Mianserin—CYP2B6—nervous system—epilepsy syndrome	4.6e-05	0.00141	CbGeAlD
Mianserin—HTR7—brain—epilepsy syndrome	4.6e-05	0.00141	CbGeAlD
Mianserin—HTR2A—midbrain—epilepsy syndrome	4.57e-05	0.0014	CbGeAlD
Mianserin—HRH1—nervous system—epilepsy syndrome	4.49e-05	0.00138	CbGeAlD
Mianserin—HTR2A—spinal cord—epilepsy syndrome	4.45e-05	0.00137	CbGeAlD
Mianserin—CYP2B6—central nervous system—epilepsy syndrome	4.43e-05	0.00136	CbGeAlD
Mianserin—ADRA2A—nervous system—epilepsy syndrome	4.41e-05	0.00135	CbGeAlD
Mianserin—Paraesthesia—Carbamazepine—epilepsy syndrome	4.36e-05	0.000633	CcSEcCtD
Mianserin—Hepatitis—Gabapentin—epilepsy syndrome	4.36e-05	0.000632	CcSEcCtD
Mianserin—Constipation—Phenytoin—epilepsy syndrome	4.35e-05	0.000632	CcSEcCtD
Mianserin—Asthenia—Levetiracetam—epilepsy syndrome	4.35e-05	0.000631	CcSEcCtD
Mianserin—DRD2—brain—epilepsy syndrome	4.35e-05	0.00133	CbGeAlD
Mianserin—Pancytopenia—Topiramate—epilepsy syndrome	4.35e-05	0.000631	CcSEcCtD
Mianserin—Pruritus—Midazolam—epilepsy syndrome	4.34e-05	0.00063	CcSEcCtD
Mianserin—Constipation—Oxcarbazepine—epilepsy syndrome	4.33e-05	0.000628	CcSEcCtD
Mianserin—HRH1—central nervous system—epilepsy syndrome	4.33e-05	0.00133	CbGeAlD
Mianserin—Somnolence—Carbamazepine—epilepsy syndrome	4.32e-05	0.000627	CcSEcCtD
Mianserin—Epinastine—ADRA2A—epilepsy syndrome	4.32e-05	0.0217	CrCbGaD
Mianserin—Angiopathy—Pregabalin—epilepsy syndrome	4.31e-05	0.000625	CcSEcCtD
Mianserin—Pruritus—Levetiracetam—epilepsy syndrome	4.29e-05	0.000622	CcSEcCtD
Mianserin—Tremor—Valproic Acid—epilepsy syndrome	4.29e-05	0.000622	CcSEcCtD
Mianserin—Neutropenia—Topiramate—epilepsy syndrome	4.28e-05	0.000621	CcSEcCtD
Mianserin—Mediastinal disorder—Pregabalin—epilepsy syndrome	4.28e-05	0.000621	CcSEcCtD
Mianserin—Connective tissue disorder—Gabapentin—epilepsy syndrome	4.28e-05	0.000621	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	4.28e-05	0.000621	CcSEcCtD
Mianserin—ADRA2A—central nervous system—epilepsy syndrome	4.25e-05	0.0013	CbGeAlD
Mianserin—Headache—Acetazolamide—epilepsy syndrome	4.23e-05	0.000614	CcSEcCtD
Mianserin—ADRA2C—brain—epilepsy syndrome	4.23e-05	0.0013	CbGeAlD
Mianserin—Anaemia—Valproic Acid—epilepsy syndrome	4.23e-05	0.000613	CcSEcCtD
Mianserin—Feeling abnormal—Clonazepam—epilepsy syndrome	4.22e-05	0.000613	CcSEcCtD
Mianserin—Paraesthesia—Lamotrigine—epilepsy syndrome	4.22e-05	0.000612	CcSEcCtD
Mianserin—Erectile dysfunction—Topiramate—epilepsy syndrome	4.22e-05	0.000612	CcSEcCtD
Mianserin—Agitation—Valproic Acid—epilepsy syndrome	4.2e-05	0.00061	CcSEcCtD
Mianserin—Asthenia—Fosphenytoin—epilepsy syndrome	4.2e-05	0.000609	CcSEcCtD
Mianserin—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	4.2e-05	0.000609	CcSEcCtD
Mianserin—Feeling abnormal—Phenytoin—epilepsy syndrome	4.2e-05	0.000609	CcSEcCtD
Mianserin—Fatigue—Carbamazepine—epilepsy syndrome	4.19e-05	0.000608	CcSEcCtD
Mianserin—Somnolence—Lamotrigine—epilepsy syndrome	4.18e-05	0.000606	CcSEcCtD
Mianserin—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	4.17e-05	0.000605	CcSEcCtD
Mianserin—Weight increased—Topiramate—epilepsy syndrome	4.17e-05	0.000604	CcSEcCtD
Mianserin—Mental disorder—Pregabalin—epilepsy syndrome	4.16e-05	0.000604	CcSEcCtD
Mianserin—Constipation—Carbamazepine—epilepsy syndrome	4.16e-05	0.000603	CcSEcCtD
Mianserin—ADRA2A—cerebellum—epilepsy syndrome	4.15e-05	0.00127	CbGeAlD
Mianserin—Dizziness—Propofol—epilepsy syndrome	4.15e-05	0.000602	CcSEcCtD
Mianserin—Pruritus—Fosphenytoin—epilepsy syndrome	4.14e-05	0.0006	CcSEcCtD
Mianserin—Vertigo—Valproic Acid—epilepsy syndrome	4.11e-05	0.000596	CcSEcCtD
Mianserin—Leukopenia—Valproic Acid—epilepsy syndrome	4.09e-05	0.000594	CcSEcCtD
Mianserin—Asthenia—Vigabatrin—epilepsy syndrome	4.09e-05	0.000593	CcSEcCtD
Mianserin—Eye disorder—Gabapentin—epilepsy syndrome	4.07e-05	0.00059	CcSEcCtD
Mianserin—Tinnitus—Gabapentin—epilepsy syndrome	4.06e-05	0.000589	CcSEcCtD
Mianserin—Dizziness—Midazolam—epilepsy syndrome	4.06e-05	0.000589	CcSEcCtD
Mianserin—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	4.06e-05	0.000588	CcSEcCtD
Mianserin—Fatigue—Lamotrigine—epilepsy syndrome	4.05e-05	0.000587	CcSEcCtD
Mianserin—Cardiac disorder—Gabapentin—epilepsy syndrome	4.04e-05	0.000586	CcSEcCtD
Mianserin—Pruritus—Vigabatrin—epilepsy syndrome	4.03e-05	0.000585	CcSEcCtD
Mianserin—Asthenia—Diazepam—epilepsy syndrome	4.03e-05	0.000584	CcSEcCtD
Mianserin—Constipation—Lamotrigine—epilepsy syndrome	4.02e-05	0.000583	CcSEcCtD
Mianserin—Dizziness—Levetiracetam—epilepsy syndrome	4.01e-05	0.000581	CcSEcCtD
Mianserin—Feeling abnormal—Carbamazepine—epilepsy syndrome	4.01e-05	0.000581	CcSEcCtD
Mianserin—Pruritus—Diazepam—epilepsy syndrome	3.97e-05	0.000576	CcSEcCtD
Mianserin—Mirtazapine—HTR7—epilepsy syndrome	3.97e-05	0.0199	CrCbGaD
Mianserin—HTR2A—head—epilepsy syndrome	3.96e-05	0.00121	CbGeAlD
Mianserin—Rash—Propofol—epilepsy syndrome	3.96e-05	0.000574	CcSEcCtD
Mianserin—Dermatitis—Propofol—epilepsy syndrome	3.95e-05	0.000573	CcSEcCtD
Mianserin—Hypertension—Valproic Acid—epilepsy syndrome	3.95e-05	0.000573	CcSEcCtD
Mianserin—Headache—Propofol—epilepsy syndrome	3.93e-05	0.00057	CcSEcCtD
Mianserin—Mediastinal disorder—Gabapentin—epilepsy syndrome	3.93e-05	0.000569	CcSEcCtD
Mianserin—Asthenia—Felbamate—epilepsy syndrome	3.9e-05	0.000565	CcSEcCtD
Mianserin—Myalgia—Valproic Acid—epilepsy syndrome	3.89e-05	0.000565	CcSEcCtD
Mianserin—Arthralgia—Valproic Acid—epilepsy syndrome	3.89e-05	0.000565	CcSEcCtD
Mianserin—Tremor—Pregabalin—epilepsy syndrome	3.87e-05	0.000562	CcSEcCtD
Mianserin—Feeling abnormal—Lamotrigine—epilepsy syndrome	3.87e-05	0.000561	CcSEcCtD
Mianserin—Rash—Midazolam—epilepsy syndrome	3.87e-05	0.000561	CcSEcCtD
Mianserin—Dizziness—Fosphenytoin—epilepsy syndrome	3.87e-05	0.000561	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	3.87e-05	0.000561	CcSEcCtD
Mianserin—Dermatitis—Midazolam—epilepsy syndrome	3.87e-05	0.000561	CcSEcCtD
Mianserin—Cyproheptadine—CHRM2—epilepsy syndrome	3.86e-05	0.0194	CrCbGaD
Mianserin—Headache—Midazolam—epilepsy syndrome	3.85e-05	0.000558	CcSEcCtD
Mianserin—Pruritus—Felbamate—epilepsy syndrome	3.84e-05	0.000558	CcSEcCtD
Mianserin—Rash—Levetiracetam—epilepsy syndrome	3.82e-05	0.000554	CcSEcCtD
Mianserin—Anaemia—Pregabalin—epilepsy syndrome	3.82e-05	0.000554	CcSEcCtD
Mianserin—Dermatitis—Levetiracetam—epilepsy syndrome	3.82e-05	0.000554	CcSEcCtD
Mianserin—Asthenia—Zonisamide—epilepsy syndrome	3.82e-05	0.000554	CcSEcCtD
Mianserin—Mental disorder—Gabapentin—epilepsy syndrome	3.82e-05	0.000553	CcSEcCtD
Mianserin—Agranulocytosis—Topiramate—epilepsy syndrome	3.81e-05	0.000553	CcSEcCtD
Mianserin—Dry mouth—Valproic Acid—epilepsy syndrome	3.81e-05	0.000552	CcSEcCtD
Mianserin—Agitation—Pregabalin—epilepsy syndrome	3.8e-05	0.000551	CcSEcCtD
Mianserin—Headache—Levetiracetam—epilepsy syndrome	3.8e-05	0.000551	CcSEcCtD
Mianserin—Dizziness—Vigabatrin—epilepsy syndrome	3.77e-05	0.000547	CcSEcCtD
Mianserin—Confusional state—Valproic Acid—epilepsy syndrome	3.76e-05	0.000546	CcSEcCtD
Mianserin—Pruritus—Zonisamide—epilepsy syndrome	3.76e-05	0.000546	CcSEcCtD
Mianserin—HTR2A—nervous system—epilepsy syndrome	3.75e-05	0.00115	CbGeAlD
Mianserin—Oedema—Valproic Acid—epilepsy syndrome	3.73e-05	0.000541	CcSEcCtD
Mianserin—Bradycardia—Topiramate—epilepsy syndrome	3.73e-05	0.000541	CcSEcCtD
Mianserin—Vertigo—Pregabalin—epilepsy syndrome	3.72e-05	0.000539	CcSEcCtD
Mianserin—Dizziness—Diazepam—epilepsy syndrome	3.71e-05	0.000538	CcSEcCtD
Mianserin—Syncope—Pregabalin—epilepsy syndrome	3.71e-05	0.000538	CcSEcCtD
Mianserin—Leukopenia—Pregabalin—epilepsy syndrome	3.7e-05	0.000537	CcSEcCtD
Mianserin—Rash—Fosphenytoin—epilepsy syndrome	3.69e-05	0.000535	CcSEcCtD
Mianserin—Dermatitis—Fosphenytoin—epilepsy syndrome	3.69e-05	0.000535	CcSEcCtD
Mianserin—Asthenia—Clonazepam—epilepsy syndrome	3.68e-05	0.000533	CcSEcCtD
Mianserin—Headache—Fosphenytoin—epilepsy syndrome	3.67e-05	0.000532	CcSEcCtD
Mianserin—Hepatitis—Topiramate—epilepsy syndrome	3.66e-05	0.000531	CcSEcCtD
Mianserin—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.66e-05	0.000531	CcSEcCtD
Mianserin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.65e-05	0.00053	CcSEcCtD
Mianserin—Asthenia—Phenytoin—epilepsy syndrome	3.65e-05	0.00053	CcSEcCtD
Mianserin—Tachycardia—Valproic Acid—epilepsy syndrome	3.64e-05	0.000528	CcSEcCtD
Mianserin—Loss of consciousness—Pregabalin—epilepsy syndrome	3.63e-05	0.000527	CcSEcCtD
Mianserin—Asthenia—Oxcarbazepine—epilepsy syndrome	3.63e-05	0.000527	CcSEcCtD
Mianserin—Pruritus—Clonazepam—epilepsy syndrome	3.63e-05	0.000526	CcSEcCtD
Mianserin—Skin disorder—Valproic Acid—epilepsy syndrome	3.63e-05	0.000526	CcSEcCtD
Mianserin—HTR2A—central nervous system—epilepsy syndrome	3.61e-05	0.00111	CbGeAlD
Mianserin—CYP2D6—head—epilepsy syndrome	3.61e-05	0.00111	CbGeAlD
Mianserin—Pruritus—Phenytoin—epilepsy syndrome	3.6e-05	0.000523	CcSEcCtD
Mianserin—Connective tissue disorder—Topiramate—epilepsy syndrome	3.6e-05	0.000522	CcSEcCtD
Mianserin—Rash—Vigabatrin—epilepsy syndrome	3.6e-05	0.000522	CcSEcCtD
Mianserin—Dizziness—Felbamate—epilepsy syndrome	3.59e-05	0.000521	CcSEcCtD
Mianserin—Dermatitis—Vigabatrin—epilepsy syndrome	3.59e-05	0.000521	CcSEcCtD
Mianserin—Pruritus—Oxcarbazepine—epilepsy syndrome	3.58e-05	0.00052	CcSEcCtD
Mianserin—Convulsion—Pregabalin—epilepsy syndrome	3.58e-05	0.00052	CcSEcCtD
Mianserin—Headache—Vigabatrin—epilepsy syndrome	3.57e-05	0.000518	CcSEcCtD
Mianserin—Hypertension—Pregabalin—epilepsy syndrome	3.57e-05	0.000518	CcSEcCtD
Mianserin—Tremor—Gabapentin—epilepsy syndrome	3.55e-05	0.000515	CcSEcCtD
Mianserin—Rash—Diazepam—epilepsy syndrome	3.54e-05	0.000513	CcSEcCtD
Mianserin—Dermatitis—Diazepam—epilepsy syndrome	3.54e-05	0.000513	CcSEcCtD
Mianserin—HTR2A—cerebellum—epilepsy syndrome	3.53e-05	0.00108	CbGeAlD
Mianserin—Myalgia—Pregabalin—epilepsy syndrome	3.52e-05	0.000511	CcSEcCtD
Mianserin—Arthralgia—Pregabalin—epilepsy syndrome	3.52e-05	0.000511	CcSEcCtD
Mianserin—Dizziness—Zonisamide—epilepsy syndrome	3.52e-05	0.00051	CcSEcCtD
Mianserin—Headache—Diazepam—epilepsy syndrome	3.52e-05	0.00051	CcSEcCtD
Mianserin—CYP2B6—brain—epilepsy syndrome	3.52e-05	0.00108	CbGeAlD
Mianserin—Anaemia—Gabapentin—epilepsy syndrome	3.5e-05	0.000508	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.5e-05	0.000507	CcSEcCtD
Mianserin—Hypotension—Valproic Acid—epilepsy syndrome	3.49e-05	0.000506	CcSEcCtD
Mianserin—Asthenia—Carbamazepine—epilepsy syndrome	3.49e-05	0.000506	CcSEcCtD
Mianserin—Agitation—Gabapentin—epilepsy syndrome	3.48e-05	0.000505	CcSEcCtD
Mianserin—CYP3A4—nervous system—epilepsy syndrome	3.47e-05	0.00106	CbGeAlD
Mianserin—Dry mouth—Pregabalin—epilepsy syndrome	3.44e-05	0.000499	CcSEcCtD
Mianserin—Pruritus—Carbamazepine—epilepsy syndrome	3.44e-05	0.000499	CcSEcCtD
Mianserin—Nortriptyline—CHRM3—epilepsy syndrome	3.44e-05	0.0173	CrCbGaD
Mianserin—HRH1—brain—epilepsy syndrome	3.43e-05	0.00105	CbGeAlD
Mianserin—Rash—Felbamate—epilepsy syndrome	3.43e-05	0.000497	CcSEcCtD
Mianserin—Eye disorder—Topiramate—epilepsy syndrome	3.42e-05	0.000497	CcSEcCtD
Mianserin—Dermatitis—Felbamate—epilepsy syndrome	3.42e-05	0.000496	CcSEcCtD
Mianserin—CYP2D6—nervous system—epilepsy syndrome	3.42e-05	0.00105	CbGeAlD
Mianserin—Tinnitus—Topiramate—epilepsy syndrome	3.42e-05	0.000496	CcSEcCtD
Mianserin—Vertigo—Gabapentin—epilepsy syndrome	3.41e-05	0.000494	CcSEcCtD
Mianserin—Headache—Felbamate—epilepsy syndrome	3.4e-05	0.000494	CcSEcCtD
Mianserin—Confusional state—Pregabalin—epilepsy syndrome	3.4e-05	0.000494	CcSEcCtD
Mianserin—Mirtazapine—ADRA2A—epilepsy syndrome	3.4e-05	0.0171	CrCbGaD
Mianserin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.4e-05	0.000493	CcSEcCtD
Mianserin—Cardiac disorder—Topiramate—epilepsy syndrome	3.4e-05	0.000493	CcSEcCtD
Mianserin—Syncope—Gabapentin—epilepsy syndrome	3.4e-05	0.000493	CcSEcCtD
Mianserin—Leukopenia—Gabapentin—epilepsy syndrome	3.39e-05	0.000492	CcSEcCtD
Mianserin—Dizziness—Clonazepam—epilepsy syndrome	3.39e-05	0.000492	CcSEcCtD
Mianserin—Oedema—Pregabalin—epilepsy syndrome	3.37e-05	0.000489	CcSEcCtD
Mianserin—ADRA2A—brain—epilepsy syndrome	3.37e-05	0.00103	CbGeAlD
Mianserin—Asthenia—Lamotrigine—epilepsy syndrome	3.37e-05	0.000489	CcSEcCtD
Mianserin—Dizziness—Phenytoin—epilepsy syndrome	3.37e-05	0.000488	CcSEcCtD
Mianserin—Rash—Zonisamide—epilepsy syndrome	3.35e-05	0.000486	CcSEcCtD
Mianserin—Paraesthesia—Valproic Acid—epilepsy syndrome	3.35e-05	0.000486	CcSEcCtD
Mianserin—Dermatitis—Zonisamide—epilepsy syndrome	3.35e-05	0.000486	CcSEcCtD
Mianserin—Dizziness—Oxcarbazepine—epilepsy syndrome	3.35e-05	0.000486	CcSEcCtD
Mianserin—CYP3A4—central nervous system—epilepsy syndrome	3.35e-05	0.00103	CbGeAlD
Mianserin—Loss of consciousness—Gabapentin—epilepsy syndrome	3.33e-05	0.000483	CcSEcCtD
Mianserin—Headache—Zonisamide—epilepsy syndrome	3.33e-05	0.000483	CcSEcCtD
Mianserin—Angiopathy—Topiramate—epilepsy syndrome	3.32e-05	0.000482	CcSEcCtD
Mianserin—Pruritus—Lamotrigine—epilepsy syndrome	3.32e-05	0.000482	CcSEcCtD
Mianserin—Shock—Pregabalin—epilepsy syndrome	3.32e-05	0.000482	CcSEcCtD
Mianserin—Somnolence—Valproic Acid—epilepsy syndrome	3.32e-05	0.000481	CcSEcCtD
Mianserin—Nervous system disorder—Pregabalin—epilepsy syndrome	3.31e-05	0.00048	CcSEcCtD
Mianserin—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.3e-05	0.000479	CcSEcCtD
Mianserin—Mediastinal disorder—Topiramate—epilepsy syndrome	3.3e-05	0.000479	CcSEcCtD
Mianserin—Tachycardia—Pregabalin—epilepsy syndrome	3.29e-05	0.000478	CcSEcCtD
Mianserin—CYP2D6—central nervous system—epilepsy syndrome	3.29e-05	0.00101	CbGeAlD
Mianserin—Convulsion—Gabapentin—epilepsy syndrome	3.29e-05	0.000476	CcSEcCtD
Mianserin—Skin disorder—Pregabalin—epilepsy syndrome	3.28e-05	0.000475	CcSEcCtD
Mianserin—Hypertension—Gabapentin—epilepsy syndrome	3.27e-05	0.000475	CcSEcCtD
Mianserin—Prochlorperazine—CHRM2—epilepsy syndrome	3.24e-05	0.0163	CrCbGaD
Mianserin—Rash—Clonazepam—epilepsy syndrome	3.23e-05	0.000469	CcSEcCtD
Mianserin—Dermatitis—Clonazepam—epilepsy syndrome	3.23e-05	0.000468	CcSEcCtD
Mianserin—Arthralgia—Gabapentin—epilepsy syndrome	3.23e-05	0.000468	CcSEcCtD
Mianserin—Myalgia—Gabapentin—epilepsy syndrome	3.23e-05	0.000468	CcSEcCtD
Mianserin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.22e-05	0.000467	CcSEcCtD
Mianserin—Fatigue—Valproic Acid—epilepsy syndrome	3.22e-05	0.000467	CcSEcCtD
Mianserin—CYP2D6—cerebellum—epilepsy syndrome	3.22e-05	0.000986	CbGeAlD
Mianserin—Dizziness—Carbamazepine—epilepsy syndrome	3.21e-05	0.000466	CcSEcCtD
Mianserin—Headache—Clonazepam—epilepsy syndrome	3.21e-05	0.000466	CcSEcCtD
Mianserin—Rash—Phenytoin—epilepsy syndrome	3.21e-05	0.000466	CcSEcCtD
Mianserin—Mental disorder—Topiramate—epilepsy syndrome	3.21e-05	0.000466	CcSEcCtD
Mianserin—Dermatitis—Phenytoin—epilepsy syndrome	3.21e-05	0.000465	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.21e-05	0.000465	CcSEcCtD
Mianserin—Nortriptyline—CHRM1—epilepsy syndrome	3.21e-05	0.0161	CrCbGaD
Mianserin—Rash—Oxcarbazepine—epilepsy syndrome	3.19e-05	0.000463	CcSEcCtD
Mianserin—Constipation—Valproic Acid—epilepsy syndrome	3.19e-05	0.000463	CcSEcCtD
Mianserin—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.19e-05	0.000463	CcSEcCtD
Mianserin—Headache—Phenytoin—epilepsy syndrome	3.19e-05	0.000463	CcSEcCtD
Mianserin—Headache—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.00046	CcSEcCtD
Mianserin—Dry mouth—Gabapentin—epilepsy syndrome	3.16e-05	0.000458	CcSEcCtD
Mianserin—Hypotension—Pregabalin—epilepsy syndrome	3.15e-05	0.000457	CcSEcCtD
Mianserin—Confusional state—Gabapentin—epilepsy syndrome	3.12e-05	0.000453	CcSEcCtD
Mianserin—Dizziness—Lamotrigine—epilepsy syndrome	3.11e-05	0.000451	CcSEcCtD
Mianserin—Oedema—Gabapentin—epilepsy syndrome	3.09e-05	0.000449	CcSEcCtD
Mianserin—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.08e-05	0.000446	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.07e-05	0.000446	CcSEcCtD
Mianserin—Rash—Carbamazepine—epilepsy syndrome	3.06e-05	0.000444	CcSEcCtD
Mianserin—Dermatitis—Carbamazepine—epilepsy syndrome	3.06e-05	0.000444	CcSEcCtD
Mianserin—Headache—Carbamazepine—epilepsy syndrome	3.05e-05	0.000442	CcSEcCtD
Mianserin—Shock—Gabapentin—epilepsy syndrome	3.04e-05	0.000442	CcSEcCtD
Mianserin—Nervous system disorder—Gabapentin—epilepsy syndrome	3.03e-05	0.00044	CcSEcCtD
Mianserin—Paraesthesia—Pregabalin—epilepsy syndrome	3.03e-05	0.00044	CcSEcCtD
Mianserin—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.03e-05	0.000439	CcSEcCtD
Mianserin—Tachycardia—Gabapentin—epilepsy syndrome	3.02e-05	0.000438	CcSEcCtD
Mianserin—Skin disorder—Gabapentin—epilepsy syndrome	3.01e-05	0.000436	CcSEcCtD
Mianserin—Somnolence—Pregabalin—epilepsy syndrome	3e-05	0.000435	CcSEcCtD
Mianserin—Tremor—Topiramate—epilepsy syndrome	2.99e-05	0.000433	CcSEcCtD
Mianserin—Rash—Lamotrigine—epilepsy syndrome	2.96e-05	0.00043	CcSEcCtD
Mianserin—Dermatitis—Lamotrigine—epilepsy syndrome	2.96e-05	0.000429	CcSEcCtD
Mianserin—Anaemia—Topiramate—epilepsy syndrome	2.95e-05	0.000428	CcSEcCtD
Mianserin—Headache—Lamotrigine—epilepsy syndrome	2.94e-05	0.000427	CcSEcCtD
Mianserin—Agitation—Topiramate—epilepsy syndrome	2.93e-05	0.000425	CcSEcCtD
Mianserin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.91e-05	0.000423	CcSEcCtD
Mianserin—Fatigue—Pregabalin—epilepsy syndrome	2.91e-05	0.000422	CcSEcCtD
Mianserin—Hypotension—Gabapentin—epilepsy syndrome	2.89e-05	0.000419	CcSEcCtD
Mianserin—Constipation—Pregabalin—epilepsy syndrome	2.89e-05	0.000419	CcSEcCtD
Mianserin—Oxcarbazepine—CYP2C19—epilepsy syndrome	2.88e-05	0.0145	CrCbGaD
Mianserin—HTR2A—brain—epilepsy syndrome	2.87e-05	0.000879	CbGeAlD
Mianserin—Vertigo—Topiramate—epilepsy syndrome	2.87e-05	0.000416	CcSEcCtD
Mianserin—Syncope—Topiramate—epilepsy syndrome	2.86e-05	0.000415	CcSEcCtD
Mianserin—Leukopenia—Topiramate—epilepsy syndrome	2.86e-05	0.000414	CcSEcCtD
Mianserin—Desipramine—CHRM3—epilepsy syndrome	2.83e-05	0.0142	CrCbGaD
Mianserin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.82e-05	0.000409	CcSEcCtD
Mianserin—Amitriptyline—OPRD1—epilepsy syndrome	2.81e-05	0.0141	CrCbGaD
Mianserin—Loss of consciousness—Topiramate—epilepsy syndrome	2.8e-05	0.000407	CcSEcCtD
Mianserin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.78e-05	0.000403	CcSEcCtD
Mianserin—Paraesthesia—Gabapentin—epilepsy syndrome	2.78e-05	0.000403	CcSEcCtD
Mianserin—Convulsion—Topiramate—epilepsy syndrome	2.76e-05	0.000401	CcSEcCtD
Mianserin—Hypertension—Topiramate—epilepsy syndrome	2.75e-05	0.000399	CcSEcCtD
Mianserin—Somnolence—Gabapentin—epilepsy syndrome	2.75e-05	0.000399	CcSEcCtD
Mianserin—Myalgia—Topiramate—epilepsy syndrome	2.72e-05	0.000394	CcSEcCtD
Mianserin—Arthralgia—Topiramate—epilepsy syndrome	2.72e-05	0.000394	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.7e-05	0.000391	CcSEcCtD
Mianserin—Asthenia—Valproic Acid—epilepsy syndrome	2.68e-05	0.000388	CcSEcCtD
Mianserin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.67e-05	0.000387	CcSEcCtD
Mianserin—Fatigue—Gabapentin—epilepsy syndrome	2.67e-05	0.000387	CcSEcCtD
Mianserin—Dry mouth—Topiramate—epilepsy syndrome	2.66e-05	0.000385	CcSEcCtD
Mianserin—Constipation—Gabapentin—epilepsy syndrome	2.65e-05	0.000384	CcSEcCtD
Mianserin—Pruritus—Valproic Acid—epilepsy syndrome	2.64e-05	0.000383	CcSEcCtD
Mianserin—Desipramine—CHRM1—epilepsy syndrome	2.64e-05	0.0133	CrCbGaD
Mianserin—Confusional state—Topiramate—epilepsy syndrome	2.63e-05	0.000381	CcSEcCtD
Mianserin—Nortriptyline—CHRM2—epilepsy syndrome	2.62e-05	0.0132	CrCbGaD
Mianserin—CYP2D6—brain—epilepsy syndrome	2.61e-05	0.000801	CbGeAlD
Mianserin—Oedema—Topiramate—epilepsy syndrome	2.6e-05	0.000378	CcSEcCtD
Mianserin—Mirtazapine—SLC6A4—epilepsy syndrome	2.59e-05	0.013	CrCbGaD
Mianserin—Shock—Topiramate—epilepsy syndrome	2.56e-05	0.000371	CcSEcCtD
Mianserin—Nervous system disorder—Topiramate—epilepsy syndrome	2.55e-05	0.00037	CcSEcCtD
Mianserin—Feeling abnormal—Gabapentin—epilepsy syndrome	2.55e-05	0.00037	CcSEcCtD
Mianserin—Thrombocytopenia—Topiramate—epilepsy syndrome	2.55e-05	0.00037	CcSEcCtD
Mianserin—Tachycardia—Topiramate—epilepsy syndrome	2.54e-05	0.000369	CcSEcCtD
Mianserin—Epinastine—HTR2A—epilepsy syndrome	2.53e-05	0.0127	CrCbGaD
Mianserin—Skin disorder—Topiramate—epilepsy syndrome	2.53e-05	0.000367	CcSEcCtD
Mianserin—Dizziness—Valproic Acid—epilepsy syndrome	2.47e-05	0.000358	CcSEcCtD
Mianserin—Hypotension—Topiramate—epilepsy syndrome	2.43e-05	0.000353	CcSEcCtD
Mianserin—Asthenia—Pregabalin—epilepsy syndrome	2.42e-05	0.000351	CcSEcCtD
Mianserin—Imipramine—CHRM3—epilepsy syndrome	2.4e-05	0.0121	CrCbGaD
Mianserin—Pruritus—Pregabalin—epilepsy syndrome	2.39e-05	0.000346	CcSEcCtD
Mianserin—Amitriptyline—CHRM3—epilepsy syndrome	2.39e-05	0.012	CrCbGaD
Mianserin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.37e-05	0.000344	CcSEcCtD
Mianserin—Rash—Valproic Acid—epilepsy syndrome	2.35e-05	0.000341	CcSEcCtD
Mianserin—Dermatitis—Valproic Acid—epilepsy syndrome	2.35e-05	0.000341	CcSEcCtD
Mianserin—Headache—Valproic Acid—epilepsy syndrome	2.34e-05	0.000339	CcSEcCtD
Mianserin—Paraesthesia—Topiramate—epilepsy syndrome	2.34e-05	0.000339	CcSEcCtD
Mianserin—Epinastine—CYP2D6—epilepsy syndrome	2.32e-05	0.0116	CrCbGaD
Mianserin—Somnolence—Topiramate—epilepsy syndrome	2.31e-05	0.000336	CcSEcCtD
Mianserin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.25e-05	0.000326	CcSEcCtD
Mianserin—Fatigue—Topiramate—epilepsy syndrome	2.24e-05	0.000326	CcSEcCtD
Mianserin—Imipramine—CHRM1—epilepsy syndrome	2.24e-05	0.0113	CrCbGaD
Mianserin—Dizziness—Pregabalin—epilepsy syndrome	2.23e-05	0.000324	CcSEcCtD
Mianserin—Constipation—Topiramate—epilepsy syndrome	2.23e-05	0.000323	CcSEcCtD
Mianserin—Amitriptyline—CHRM1—epilepsy syndrome	2.22e-05	0.0112	CrCbGaD
Mianserin—Asthenia—Gabapentin—epilepsy syndrome	2.22e-05	0.000322	CcSEcCtD
Mianserin—Pruritus—Gabapentin—epilepsy syndrome	2.19e-05	0.000318	CcSEcCtD
Mianserin—Mequitazine—CYP2D6—epilepsy syndrome	2.18e-05	0.011	CrCbGaD
Mianserin—Desipramine—CHRM2—epilepsy syndrome	2.16e-05	0.0108	CrCbGaD
Mianserin—Amitriptyline—OPRM1—epilepsy syndrome	2.15e-05	0.0108	CrCbGaD
Mianserin—Feeling abnormal—Topiramate—epilepsy syndrome	2.15e-05	0.000311	CcSEcCtD
Mianserin—Rash—Pregabalin—epilepsy syndrome	2.13e-05	0.000309	CcSEcCtD
Mianserin—Dermatitis—Pregabalin—epilepsy syndrome	2.13e-05	0.000308	CcSEcCtD
Mianserin—Headache—Pregabalin—epilepsy syndrome	2.11e-05	0.000307	CcSEcCtD
Mianserin—Trimipramine—ADRA2A—epilepsy syndrome	2.1e-05	0.0106	CrCbGaD
Mianserin—Dizziness—Gabapentin—epilepsy syndrome	2.05e-05	0.000297	CcSEcCtD
Mianserin—Mirtazapine—HTR2A—epilepsy syndrome	1.99e-05	0.01	CrCbGaD
Mianserin—Rash—Gabapentin—epilepsy syndrome	1.95e-05	0.000283	CcSEcCtD
Mianserin—Dermatitis—Gabapentin—epilepsy syndrome	1.95e-05	0.000283	CcSEcCtD
Mianserin—Headache—Gabapentin—epilepsy syndrome	1.94e-05	0.000281	CcSEcCtD
Mianserin—Cyproheptadine—HTR2A—epilepsy syndrome	1.93e-05	0.00972	CrCbGaD
Mianserin—Asthenia—Topiramate—epilepsy syndrome	1.87e-05	0.000271	CcSEcCtD
Mianserin—Pruritus—Topiramate—epilepsy syndrome	1.84e-05	0.000267	CcSEcCtD
Mianserin—Imipramine—CHRM2—epilepsy syndrome	1.83e-05	0.00919	CrCbGaD
Mianserin—Mirtazapine—CYP2D6—epilepsy syndrome	1.82e-05	0.00917	CrCbGaD
Mianserin—Imipramine—HTR7—epilepsy syndrome	1.82e-05	0.00914	CrCbGaD
Mianserin—Amitriptyline—CHRM2—epilepsy syndrome	1.82e-05	0.00913	CrCbGaD
Mianserin—Amitriptyline—HTR7—epilepsy syndrome	1.81e-05	0.00909	CrCbGaD
Mianserin—Dizziness—Topiramate—epilepsy syndrome	1.72e-05	0.00025	CcSEcCtD
Mianserin—Nortriptyline—SLC6A4—epilepsy syndrome	1.7e-05	0.00857	CrCbGaD
Mianserin—Epinastine—ABCB1—epilepsy syndrome	1.65e-05	0.00831	CrCbGaD
Mianserin—Rash—Topiramate—epilepsy syndrome	1.64e-05	0.000238	CcSEcCtD
Mianserin—Dermatitis—Topiramate—epilepsy syndrome	1.64e-05	0.000238	CcSEcCtD
Mianserin—Headache—Topiramate—epilepsy syndrome	1.63e-05	0.000237	CcSEcCtD
Mianserin—Nortriptyline—CYP2C19—epilepsy syndrome	1.62e-05	0.00812	CrCbGaD
Mianserin—Trimipramine—SLC6A4—epilepsy syndrome	1.6e-05	0.00806	CrCbGaD
Mianserin—Oxcarbazepine—ALB—epilepsy syndrome	1.6e-05	0.00803	CrCbGaD
Mianserin—Amitriptyline—ADRA2A—epilepsy syndrome	1.55e-05	0.00779	CrCbGaD
Mianserin—Trimipramine—CYP2C19—epilepsy syndrome	1.52e-05	0.00765	CrCbGaD
Mianserin—Prochlorperazine—CYP2D6—epilepsy syndrome	1.48e-05	0.00745	CrCbGaD
Mianserin—Desipramine—SLC6A4—epilepsy syndrome	1.4e-05	0.00705	CrCbGaD
Mianserin—Desipramine—CYP2C19—epilepsy syndrome	1.33e-05	0.00669	CrCbGaD
Mianserin—Nortriptyline—HTR2A—epilepsy syndrome	1.31e-05	0.00658	CrCbGaD
Mianserin—Trimipramine—HTR2A—epilepsy syndrome	1.23e-05	0.0062	CrCbGaD
Mianserin—Nortriptyline—CYP2D6—epilepsy syndrome	1.2e-05	0.00602	CrCbGaD
Mianserin—Imipramine—SLC6A4—epilepsy syndrome	1.19e-05	0.00598	CrCbGaD
Mianserin—Amitriptyline—SLC6A4—epilepsy syndrome	1.18e-05	0.00594	CrCbGaD
Mianserin—Imipramine—CYP2C19—epilepsy syndrome	1.13e-05	0.00567	CrCbGaD
Mianserin—Trimipramine—CYP2D6—epilepsy syndrome	1.13e-05	0.00567	CrCbGaD
Mianserin—Amitriptyline—CYP2C19—epilepsy syndrome	1.12e-05	0.00563	CrCbGaD
Mianserin—Desipramine—HTR2A—epilepsy syndrome	1.08e-05	0.00542	CrCbGaD
Mianserin—Desipramine—CYP2D6—epilepsy syndrome	9.86e-06	0.00496	CrCbGaD
Mianserin—Imipramine—HTR2A—epilepsy syndrome	9.15e-06	0.0046	CrCbGaD
Mianserin—Amitriptyline—HTR2A—epilepsy syndrome	9.09e-06	0.00457	CrCbGaD
Mianserin—Nortriptyline—ALB—epilepsy syndrome	8.96e-06	0.0045	CrCbGaD
Mianserin—Imipramine—CYP2D6—epilepsy syndrome	8.36e-06	0.0042	CrCbGaD
Mianserin—Amitriptyline—CYP2D6—epilepsy syndrome	8.31e-06	0.00418	CrCbGaD
Mianserin—Trimipramine—ABCB1—epilepsy syndrome	8.05e-06	0.00405	CrCbGaD
Mianserin—Desipramine—ABCB1—epilepsy syndrome	7.04e-06	0.00354	CrCbGaD
Mianserin—Amitriptyline—ALB—epilepsy syndrome	6.22e-06	0.00313	CrCbGaD
Mianserin—Imipramine—ABCB1—epilepsy syndrome	5.97e-06	0.003	CrCbGaD
Mianserin—Amitriptyline—ABCB1—epilepsy syndrome	5.94e-06	0.00298	CrCbGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.11e-07	1.1e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	6.09e-07	1.1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	6.08e-07	1.1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ALB—epilepsy syndrome	6.07e-07	1.09e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AGT—epilepsy syndrome	6.02e-07	1.08e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.01e-07	1.08e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	6e-07	1.08e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AGT—epilepsy syndrome	6e-07	1.08e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	5.96e-07	1.07e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	5.94e-07	1.07e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	5.91e-07	1.06e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	5.9e-07	1.06e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—APOE—epilepsy syndrome	5.9e-07	1.06e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	5.9e-07	1.06e-05	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.89e-07	1.06e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AGT—epilepsy syndrome	5.89e-07	1.06e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APOE—epilepsy syndrome	5.88e-07	1.06e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	5.84e-07	1.05e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	5.83e-07	1.05e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	5.83e-07	1.05e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	5.82e-07	1.05e-05	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	5.8e-07	1.05e-05	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	5.8e-07	1.04e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	5.8e-07	1.04e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	5.78e-07	1.04e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	5.78e-07	1.04e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	5.77e-07	1.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APOE—epilepsy syndrome	5.77e-07	1.04e-05	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	5.76e-07	1.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KDR—epilepsy syndrome	5.76e-07	1.04e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	5.75e-07	1.04e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	5.75e-07	1.04e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	5.74e-07	1.04e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	5.72e-07	1.03e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	5.71e-07	1.03e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	5.71e-07	1.03e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	5.67e-07	1.02e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	5.66e-07	1.02e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	5.66e-07	1.02e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KDR—epilepsy syndrome	5.65e-07	1.02e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	5.63e-07	1.01e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	5.6e-07	1.01e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—JUN—epilepsy syndrome	5.59e-07	1.01e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—JUN—epilepsy syndrome	5.58e-07	1.01e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	5.56e-07	1e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	5.54e-07	9.99e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	5.54e-07	9.99e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	5.52e-07	9.95e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	5.51e-07	9.94e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	5.51e-07	9.93e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	5.45e-07	9.83e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	5.45e-07	9.82e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	5.44e-07	9.81e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	5.44e-07	9.81e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	5.43e-07	9.79e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	5.43e-07	9.79e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	5.43e-07	9.78e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TH—epilepsy syndrome	5.43e-07	9.78e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	5.42e-07	9.77e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—RELA—epilepsy syndrome	5.42e-07	9.76e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—POMC—epilepsy syndrome	5.4e-07	9.74e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	5.39e-07	9.72e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.38e-07	9.69e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	5.38e-07	9.69e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	5.37e-07	9.68e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	5.35e-07	9.64e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	5.35e-07	9.64e-06	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	5.34e-07	9.63e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.34e-07	9.63e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	5.31e-07	9.57e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	5.31e-07	9.56e-06	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.3e-07	9.55e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAT—epilepsy syndrome	5.28e-07	9.51e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	5.27e-07	9.5e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	5.27e-07	9.49e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	5.27e-07	9.49e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	5.26e-07	9.48e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	5.25e-07	9.46e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.24e-07	9.44e-06	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—AKT1—epilepsy syndrome	5.24e-07	9.44e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	5.23e-07	9.43e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.21e-07	9.39e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	5.15e-07	9.29e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	5.13e-07	9.25e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	5.1e-07	9.19e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	5.08e-07	9.16e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	5.08e-07	9.16e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—POMC—epilepsy syndrome	5.07e-07	9.13e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	5.06e-07	9.12e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—POMC—epilepsy syndrome	5.05e-07	9.1e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—SRC—epilepsy syndrome	5.01e-07	9.03e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—SRC—epilepsy syndrome	5.01e-07	9.02e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	4.97e-07	8.96e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.97e-07	8.95e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	4.96e-07	8.94e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.96e-07	8.94e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—POMC—epilepsy syndrome	4.96e-07	8.93e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	4.95e-07	8.92e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.94e-07	8.9e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.94e-07	8.9e-06	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.93e-07	8.89e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ALB—epilepsy syndrome	4.93e-07	8.88e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	4.92e-07	8.87e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	4.89e-07	8.81e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	4.88e-07	8.8e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	4.88e-07	8.8e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	4.87e-07	8.79e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	4.86e-07	8.76e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	4.85e-07	8.74e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	4.84e-07	8.73e-06	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—AKT1—epilepsy syndrome	4.83e-07	8.71e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.81e-07	8.67e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	4.79e-07	8.64e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	4.77e-07	8.6e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—JUN—epilepsy syndrome	4.74e-07	8.55e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	4.72e-07	8.51e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.7e-07	8.47e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	4.7e-07	8.46e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	4.63e-07	8.34e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ALB—epilepsy syndrome	4.62e-07	8.33e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	4.62e-07	8.32e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	4.6e-07	8.3e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	4.57e-07	8.24e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	4.57e-07	8.23e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	4.53e-07	8.16e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	4.52e-07	8.14e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	4.48e-07	8.07e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	4.48e-07	8.07e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.47e-07	8.06e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAT—epilepsy syndrome	4.47e-07	8.06e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	4.46e-07	8.05e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.46e-07	8.03e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.45e-07	8.03e-06	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.45e-07	8.02e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	4.42e-07	7.97e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.41e-07	7.95e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	4.39e-07	7.92e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	4.38e-07	7.9e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	4.35e-07	7.84e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	4.31e-07	7.77e-06	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.3e-07	7.74e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	4.28e-07	7.72e-06	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.27e-07	7.7e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	4.26e-07	7.67e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—SRC—epilepsy syndrome	4.26e-07	7.67e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.25e-07	7.66e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	4.24e-07	7.63e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.2e-07	7.58e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TH—epilepsy syndrome	4.19e-07	7.55e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AGT—epilepsy syndrome	4.18e-07	7.54e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	4.17e-07	7.51e-06	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	4.16e-07	7.49e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	4.14e-07	7.47e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—RELA—epilepsy syndrome	4.14e-07	7.47e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	4.13e-07	7.45e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	4.12e-07	7.42e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	4.11e-07	7.41e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—epilepsy syndrome	4.1e-07	7.39e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	4.08e-07	7.35e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—RELA—epilepsy syndrome	4.07e-07	7.33e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	4.06e-07	7.32e-06	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	4.06e-07	7.32e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	4.04e-07	7.28e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	4.04e-07	7.28e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	4.04e-07	7.28e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	4.02e-07	7.25e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	4e-07	7.21e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	4e-07	7.21e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	4e-07	7.21e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	4e-07	7.2e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.99e-07	7.19e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.9e-07	7.03e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.89e-07	7.02e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.88e-07	7e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.84e-07	6.92e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.78e-07	6.8e-06	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.77e-07	6.8e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-07	6.74e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.74e-07	6.74e-06	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.71e-07	6.69e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.71e-07	6.69e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.71e-07	6.68e-06	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.7e-07	6.68e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3.69e-07	6.65e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	3.68e-07	6.63e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	3.67e-07	6.61e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.64e-07	6.56e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—JUN—epilepsy syndrome	3.63e-07	6.54e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	3.61e-07	6.51e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-07	6.48e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	3.59e-07	6.47e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	3.57e-07	6.44e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—JUN—epilepsy syndrome	3.56e-07	6.42e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.54e-07	6.39e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	3.53e-07	6.37e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—POMC—epilepsy syndrome	3.52e-07	6.35e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.5e-07	6.3e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	3.5e-07	6.3e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	3.48e-07	6.26e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—epilepsy syndrome	3.47e-07	6.26e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	3.47e-07	6.25e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.45e-07	6.22e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	3.43e-07	6.17e-06	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.38e-07	6.09e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.37e-07	6.08e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	3.36e-07	6.06e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.36e-07	6.05e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	3.35e-07	6.03e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SRC—epilepsy syndrome	3.26e-07	5.87e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	3.25e-07	5.86e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—epilepsy syndrome	3.21e-07	5.79e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	3.2e-07	5.77e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SRC—epilepsy syndrome	3.2e-07	5.76e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	3.17e-07	5.72e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	3.16e-07	5.7e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	3.16e-07	5.69e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.12e-07	5.62e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.12e-07	5.62e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	3.11e-07	5.61e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	3.11e-07	5.61e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	3.11e-07	5.61e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	3.09e-07	5.57e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	3.07e-07	5.53e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.98e-07	5.38e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.92e-07	5.25e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	2.84e-07	5.12e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.84e-07	5.12e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.81e-07	5.06e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.74e-07	4.93e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.72e-07	4.9e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.68e-07	4.83e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.67e-07	4.81e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	2.64e-07	4.77e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-07	4.3e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.38e-07	4.29e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	2.3e-07	4.15e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.3e-07	4.15e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-07	4.13e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-07	4.02e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.17e-07	3.9e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.1e-07	3.78e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—epilepsy syndrome	2.03e-07	3.66e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.02e-07	3.65e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.99e-07	3.59e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.99e-07	3.58e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.84e-07	3.31e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.81e-07	3.26e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.41e-07	2.54e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.2e-07	2.16e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.23e-08	1.66e-06	CbGpPWpGaD
